XUCS:XETRA:XETRA-Xtrackers MSCI USA Consumer Staples UCITS (EUR)

ETF | Others |

Last Closing

USD 44.54

Change

-0.07 (-0.15)%

Market Cap

USD 0.09B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.26 (+0.50%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.45%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.38 (+1.37%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.13 (+0.46%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.15 (+0.58%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.25 (+0.53%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.52 (+0.36%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.25 (+0.48%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.72 (+1.64%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.86 (+0.30%)

USD 80.38B

ETFs Containing XUCS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.61% 43% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.61% 43% F 42% F
Trailing 12 Months  
Capital Gain 15.96% 63% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.96% 62% D 63% D
Trailing 5 Years  
Capital Gain 38.97% 61% D- 63% D
Dividend Return 11.08% 64% D 51% F
Total Return 50.05% 65% D 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.96% 60% D- 59% D-
Dividend Return 9.09% 59% D- 58% F
Total Return 0.13% 15% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 10.46% 61% D- 69% C-
Risk Adjusted Return 86.93% 76% C+ 79% B-
Market Capitalization 0.09B 30% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.